Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Biotech Ltd has informed BSE that the trading window for dealing in its securities will remain closed starting Wednesday, October 01, 2025, until 48 hours after the declaration of unaudited standalone and consolidated financial results for the quarter and half-year ending September 30, 2025. The closure applies to all Designated Persons, their Immediate Relatives, and Connected Persons covered under the company's insider trading code. The company is complying with SEBI (Prohibition of Insider Trading) Regulations, 2015. The date of the board meeting to approve these Q2/H1 FY26 results will be communicated separately in due course.
This is a routine compliance announcement ahead of upcoming quarterly results. It restricts insiders from trading the stock during a sensitive period, but carries no direct impact on share price or shareholders. Investors should watch for the upcoming Q2/H1 FY26 results announcement for fundamental triggers.